학술논문
P3.07-004 Nivolumab for Non-Small Cell Lung Cancer (NSCLC): An Economic Model for Risk Sharing Based on Real-Life Data: Topic: Therapy and Economics
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology January 2017 12(1) Supplement:S1432-S1433
Subject
Language
ISSN
1556-0864